Literature DB >> 15969620

Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft.

Frank P Barry1, J Mary Murphy, Karen English, Bernard P Mahon.   

Abstract

Herein we review recent data that support host tolerance of allogeneic adult mesenchymal stem cells (MSC). Evidence is emerging that donor MSC deploy a very powerful array of mechanisms that allow escape from host allogeneic responses. These mechanisms include limited expression of alloantigen by the stem cell and cell contact-dependent and -independent mechanisms. MSC modulate host dendritic cell and T cell function, promoting induction of suppressor or regulatory T cells. These effects are complemented by the induction of divisional arrest anergy in T cells and by stem cell production of soluble immunomodulatory factors, including interleukin-10, transforming growth factor-beta, prostaglandin E2, and hepatocyte growth factor. In addition, MSC express the enzyme indoleamine 2,3-dioxygenase, which creates a tryptophan-depleted milieu that promotes immunosuppression. We propose that these observations show striking similarity to emerging data on the maternal acceptance of the fetal allograft. This comparison suggests new approaches to determine the contribution of different mechanisms to the successful use of MSC in regenerative medicine.

Entities:  

Mesh:

Year:  2005        PMID: 15969620     DOI: 10.1089/scd.2005.14.252

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  48 in total

1.  Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate.

Authors:  A Poloni; G Maurizi; F Serrani; S Mancini; G Discepoli; A L Tranquilli; R Bencivenga; P Leoni
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

2.  Expression of transcriptional factor genes (Oct-4, Nanog, and Sox-2) and embryonic stem cell-like characters in placental membrane of Buffalo (Bubalus bubalis).

Authors:  Kapil Dev; Shiv Kumar Giri; Anil Kumar; Anita Yadav; Birbal Singh; Sanjeev Kumar Gautam
Journal:  J Membr Biol       Date:  2012-04-22       Impact factor: 1.843

Review 3.  Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.

Authors:  Jakob Reiser; Xian-Yang Zhang; Charles S Hemenway; Debasis Mondal; Leena Pradhan; Vincent F La Russa
Journal:  Expert Opin Biol Ther       Date:  2005-12       Impact factor: 4.388

4.  Fetal liver-derived mesenchymal stem cell engraftment after allogeneic in utero transplantation into rabbits.

Authors:  Rafael Moreno; Itziar Martínez-González; Marta Rosal; Marga Nadal; Jordi Petriz; Eduard Gratacós; Josep M Aran
Journal:  Stem Cells Dev       Date:  2011-06-01       Impact factor: 3.272

Review 5.  Immune regulation by non-lymphoid cells in transplantation.

Authors:  A-S Dugast; B Vanhove
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

6.  Stem cells to the rescue.

Authors:  Lawrence R Schiller
Journal:  Curr Gastroenterol Rep       Date:  2008-10

Review 7.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

8.  Elimination of allogeneic multipotent stromal cells by host macrophages in different models of regeneration.

Authors:  Irina Arutyunyan; Andrey Elchaninov; Timur Fatkhudinov; Andrey Makarov; Evgeniya Kananykhina; Natalia Usman; Galina Bolshakova; Valeria Glinkina; Dmitry Goldshtein; Gennady Sukhikh
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

9.  Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

Authors:  K English; J M Ryan; L Tobin; M J Murphy; F P Barry; B P Mahon
Journal:  Clin Exp Immunol       Date:  2009-02-03       Impact factor: 4.330

10.  Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease.

Authors:  Dianne M Camp; David A Loeffler; Diane M Farrah; Jade N Borneman; Peter A LeWitt
Journal:  J Neuroinflammation       Date:  2009-06-05       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.